First Time Loading...

Imeik Technology Development Co Ltd
SZSE:300896

Watchlist Manager
Imeik Technology Development Co Ltd Logo
Imeik Technology Development Co Ltd
SZSE:300896
Watchlist
Price: 214.8 CNY -1.38% Market Closed
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one Imeik Technology Development Co Ltd stock under the Base Case scenario is 137.33 CNY. Compared to the current market price of 214.8 CNY, Imeik Technology Development Co Ltd is Overvalued by 36%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
137.33 CNY
Overvaluation 36%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

30.4
P/S
P/S
Price to Sales
30.4
vs History
86
vs Industry
27
Median 3Y
65.5
Median 5Y
65
Industry
8.1
Forward
22.1
More Details
46.6
P/E
P/E
Price to Earnings
46.6
vs History
86
vs Industry
4
Median 3Y
99
Median 5Y
98.6
Industry
26.2
Forward
34.5
More Details
47.1
P/OCF
P/OCF
Price to OCF
47.1
vs History
86
vs Industry
4
Median 3Y
102.3
Median 5Y
102.1
Industry
22.6
More Details
53.5
P/FCFE
P/FCFE
Price to FCFE
53.5
vs History
86
vs Industry
3
Median 3Y
111.5
Median 5Y
105.3
Industry
21.3
More Details
10.4
P/B
P/B
Price to Book Value
10.4
vs History
93
vs Industry
8
Median 3Y
20.7
Median 5Y
19.3
Industry
2.5
More Details
28.7
EV/S
EV/S
Enterprise Value to Sales
28.7
vs History
86
vs Industry
23
Median 3Y
63
Median 5Y
62.6
Industry
7.3
Forward
20.8
More Details
30.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
30.3
vs History
86
vs Industry
19
Median 3Y
67
Median 5Y
66.9
Industry
9.1
More Details
40.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
40.4
vs History
86
vs Industry
3
Median 3Y
88.7
Median 5Y
88
Industry
4.4
Forward
28.3
More Details
40.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
40.4
vs History
86
vs Industry
3
Median 3Y
88.7
Median 5Y
88
Industry
4.3
Forward
29
More Details
44.4
EV/OCF
EV/OCF
Enterprise Value to OCF
44.4
vs History
86
vs Industry
4
Median 3Y
98.9
Median 5Y
98.6
Industry
5.4
More Details
50.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
50.4
vs History
86
vs Industry
3
Median 3Y
107.7
Median 5Y
101.5
Industry
3.2
More Details
21.5
EV/IC
EV/IC
Enterprise Value to IC
21.5
vs History
93
vs Industry
13
Median 3Y
52.7
Median 5Y
61.1
Industry
5
More Details

Multiples Across Competitors

Competitors Multiples
Imeik Technology Development Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Imeik Technology Development Co Ltd
SZSE:300896
65.1B CNY 30.4 46.6 40.4 40.4
US
Abbvie Inc
NYSE:ABBV
281.3B USD 5.2 58.4 12.7 19.4
US
Amgen Inc
NASDAQ:AMGN
148.1B USD 5.3 22 16.4 24.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.8B USD 10.5 28.7 23 24
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
101.7B USD 7.8 25.7 17.2 18.9
AU
CSL Ltd
ASX:CSL
133B AUD 6.1 35.1 21.3 26.4
US
Gilead Sciences Inc
NASDAQ:GILD
81.1B USD 3 167.6 6.7 8.8
US
Moderna Inc
NASDAQ:MRNA
45.8B USD 6.7 -9.7 -10.4 -8.9
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.3B USD 3.2 26.8 13.8 17.2
KR
Celltrion Inc
KRX:068270
38.9T KRW 17.9 72.5 44.4 61.1

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.